FDG-PET Predicts Neoadjuvant Therapy Response and Survival in Borderline Resectable/Locally Advanced Pancreatic AdenocarcinomaAmro M. Abdelrahman, Mark J. Truty, Christopher L. Hallemeier et al.|Journal of the National Comprehensive Cancer Network|2022Cited by 59
Circulating Tumor DNA Predicts Early Recurrence Following Locoregional Therapy for Oligometastatic Colorectal CancerC. O'Donnell, Zhaohui Jin, Nikolas Naleid et al.|Cancers|2024Cited by 4
Tumor-derived extracellular vesicles: A potential novel liquid biomarker for pancreatic ductal adenocarcinoma.Roman O. Kowalchuk, Kenneth W. Merrell, Krishan R. Jethwa et al.|Journal of Clinical Oncology|2025Cited by 0
Exploratory Analysis of PET and CA 19-9 Response in Pancreatic Ductal Adenocarcinoma Outcomes: A Secondary Analysis of a Prospective Phase 2 TrialKeaton Rummel, Krishan R. Jethwa, Ajit H. Goenka et al.|International Journal of Radiation Oncology*Biology*Physics|2025Cited by 0